课题基金 / 基金详情

Senior Leadership

Senior Leadership
高层领导
批准号:
8724599
负责人:
Douglas Yee
金额:
$2.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2014-01-31

项目摘要

项目成果

Douglas Yee的其他基金

相似基金

相关文献

中文摘要
翻译
7.1高级领导 7.1.1主任:DOUGLAS YEE,医学博士(50%或6 cal mos) 道格拉斯易,医学博士2007年3月被任命为癌症中心主任。Yee博士拥有Tickle家庭土地赠款乳腺癌主席和医学和药理学教授。作为主任,Yee博士向健康科学高级副总裁Frank Cerra博士报告。 博士作为主任,Yee负责和有权制定和实施癌症中心的研究使命、战略规划、教师招聘、资源开发、领导:任命和设施。中指出
英文摘要
7.1 SENIOR LEADERSHIP 7.1.1 DIRECTOR: DOUGLAS YEE, M.D. (50%, or 6 cal mos) Douglas Yee, M.D. was named Cancer Center Director March, 2007. Dr. Yee holds the Tickle Family Land Grant Chair in Breast Cancer and Professor of Medicine and Pharmacology. As Director, Dr. Yee reports to the Senior Vice President for Health Sciences, Dr. Frank Cerra. Dr. Yee, as director, has responsibility and authority for development and implementation of the Cancer Center's research mission, strategic planning, faculty recruitment, resource development, leadership: appointments, and facilities. As noted in the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Disrupting insulin receptor function in breast cancer
  • 批准号:
    10412979
  • 项目类别:
  • 资助金额:
    $33.95万
  • 财政年份:
    2020
  • 负责人:
    Douglas Yee
  • 依托单位:
Disrupting insulin receptor function in breast cancer
  • 批准号:
    10625994
  • 项目类别:
  • 资助金额:
    $33.9万
  • 财政年份:
    2020
  • 负责人:
    Douglas Yee
  • 依托单位:
Disrupting insulin receptor function in breast cancer
  • 批准号:
    10028995
  • 项目类别:
  • 资助金额:
    $34.53万
  • 财政年份:
    2020
  • 负责人:
    Douglas Yee
  • 依托单位:
Disrupting insulin receptor function in breast cancer
  • 批准号:
    10171816
  • 项目类别:
  • 资助金额:
    $34.74万
  • 财政年份:
    2020
  • 负责人:
    Douglas Yee
  • 依托单位:
海外基金